Carbapenem-resistant Enterobacteriaceae (CRE) are major health care-associated
pathogens and responsible for hospital outbreaks worldwide. To prevent a further increase …

Introduction: Antimicrobial resistance is a well-recognized global threat; thus, the
development of strong infection control policies coupled with antimicrobial stewardship …

This study was aimed to determine the risk factors of Carbapenem-resistant
Enterobacteriaceae (CRE) nosocomial infections and assess the clinical outcomes. A case …

The past decade has brought a significant rise in antimicrobial resistance, and the ESKAPE
pathogens have become a significant threat to public health. Three epidemiological features …

Background Antimicrobial resistance (AMR) causes substantial health and economic burden
to individuals, healthcare systems and societies globally. Understanding the temporal …

Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infection: A Serious Threat in
ICUs - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

Cefmetazole is active against extended-spectrum β-lactamase-producing Escherichia coli
(ESBLEC) and is a potential candidate for carbapenem-sparing therapy. This multicenter …

Full article: Risk Factors for and Clinical Outcomes of Carbapenem-Resistant Klebsiella
pneumoniae Nosocomial Infections: A Retrospective Study in a Tertiary Hospital in Beijing …

Background Carbapenemase-producing Enterobacteriaceae (CPE) are Gram-negative
bacteria with increasing prevalence of infection worldwide. In Korea, 25 cases of CPE …

OBJECTIVECarbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-
CRE) are extremely drug-resistant pathogens. Screening of contacts of newly identified CP …